lymphoma

(redirected from ALCL)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.
Related to ALCL: ACL

lymphoma,

a cancer of the tissue of the lymphatic systemlymphatic system
, network of vessels carrying lymph, or tissue-cleansing fluid, from the tissues into the veins of the circulatory system. The lymphatic system functions along with the circulatory system in absorbing nutrients from the small intestines.
..... Click the link for more information.
. There are two categories of lymphomas. One type is termed Hodgkin's diseaseHodgkin's disease,
a type of cancer of the lymphatic system. First identified in 1832 in England by Thomas Hodgkin, it is a type of malignant lymphoma. Incidence peaks in young adults and the elderly.
..... Click the link for more information.
, the other, non-Hodgkin's lymphoma (see lymphoma, non-Hodgkin'slymphoma, non-Hodgkin's,
any cancer of the lymphoid tissue (see lymphatic system) in which the Reed-Sternberg cells characteristic of Hodgkin's disease (the other category of lymphoma) are not present.
..... Click the link for more information.
). See also neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.

lymphoma

[lim′fō·mə]
(medicine)
Any neoplasm, usually malignant, of the lymphoid tissues.
References in periodicals archive ?
PTCL is less common, occurring in only 12% to 15% of HIV-affected individuals with lymphoma, of which ALCL only accounts for 28% of cases (6, 7).
Meanwhile, the FDA is teaming with the American Society of Plastic Surgeons to create a registry to better understand the development of ALCL in women with breast implants and examine reported cases.
However, the evidence of the association between implants and ALCL development has been inconclusive, said the authors.
0 years, (26-28) and ALCL rarely occurs in infants.
ADCETRIS is being evaluated across many disease settings in ongoing clinical trials in Canada, including a planned phase I/II investigator-sponsored clinical trial evaluating ADCETRIS in combination with bendamustine for patients with HL and ALCL that has either relapsed or did not respond to initial treatment.
Leukemic peripheral blood involvement in ALCL is uncommon; however, it has been reported, and an association with the small cell variant of ALCL has been established.
In this study, we describe 6 cases of ALCL involving the breast identified during 21 years at our institution.
1) The World Health Organization classification defines ALCL as a systemic lymphoma of T-cell or null-cell lineage that expresses CD30.
ADCETRIS was designated as an orphan medicinal product in Europe for both HL and ALCL by the Committee for Orphan Medicinal Products (COMP) on 15 January 2009.
For 8 children with ALCL, 7 had complete responses - no cancer could be detected with imaging scans.